Simplex Trading
CGEM icon

Simplex Trading’s Cullinan Oncology CGEM Stock Holding History

Simplex Trading’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Sell
900
-1,300
-59% -$19.3K ﹤0.01% 7288
2026
Q1 		$31.3K Sell
2,200
-16,500
-88% -$212K ﹤0.01% 6340
2025
Q4 		$194K Buy
18,700
+13,500
+260% +$122K ﹤0.01% 4268
2025
Q3 		$30K Buy
5,200
+4,800
+1,200% +$35.2K ﹤0.01% 6960
2025
Q2 		$3K Sell
400
-400
-50% -$3.21K ﹤0.01% 7941
2025
Q1 		$6K Sell
800
-1,900
-70% -$18.2K ﹤0.01% 7415
2024
Q4 		$32K Sell
2,700
-43,200
-94% -$621K ﹤0.01% 6283
2024
Q3 		$768K Buy
45,900
+18,600
+68% +$330K ﹤0.01% 3164
2024
Q2 		$476K Buy
+27,300
New +$581K ﹤0.01% 3725
2024
Q1 		– Sell
-300
Closed -$3K – 8914
2023
Q4 		$3K Hold
300
– – ﹤0.01% 8055
2023
Q3 		$2K Hold
300
– – ﹤0.01% 8048
2023
Q2 		$3K Buy
+300
New +$3.19K ﹤0.01% 8190
2022
Q4 		– Sell
-600
Closed -$7K – 9295
2022
Q3 		$7K Hold
600
– – ﹤0.01% 8505
2022
Q2 		$7K Sell
600
-600
-50% -$6.8K ﹤0.01% 8558
2022
Q1 		$12K Buy
1,200
+1,100
+1,100% +$14.9K ﹤0.01% 8718
2021
Q4 		$1K Buy
+100
New +$2K ﹤0.01% 10155

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplex Trading's CGEM Position: Q2 2026 in Review

Simplex Trading reduced its Cullinan Oncology (CGEM) stake by 1.1% in Q2 2026, selling an estimated $2.78K and leaving 17,444 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Simplex Trading first reported a position in CGEM in Q2 2022 and has held it in 13 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Simplex Trading held 17,444 shares of Cullinan Oncology worth $318K as of Q2 2026.
  • Simplex Trading sold 187 Cullinan Oncology shares in Q2 2026, an estimated $2.78K.
  • Cullinan Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4159 holding.
  • Simplex Trading first reported a position in Cullinan Oncology in Q2 2022 and has held it in 13 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.